Research Article
In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis
Table 1
Grouping and treatment protocol.
| Group | Description |
| (1) Sham | Sham-operated | (2) OVX | Ovariectomized (OVX) | (3) OVX + ELP | OVX treated with 0.35 g/kg/day ELP | (4) OVX + A | OVX treated with 0.5 mg/kg/day alendronate | (5) OVX + A (Low) | OVX treated with 0.05 mg/kg/day alendronate | (6) OVX + R | OVX treated with 2.5 mg/kg/day raloxifene | (7) OVX + R (Low) | OVX treated with 0.25 mg/kg/day raloxifene | (8) OVX + ELP + A | OVX treated with 0.35 g/kg/day ELP + 0.5 mg/kg/day alendronate | (9) OVX + ELP + A (Low) | OVX treated with 0.35 g/kg/day ELP + 0.05 mg/kg/day alendronate | (10) OVX + ELP + R | OVX treated with 0.35 g/kg/day ELP + 2.5 mg/kg/day raloxifene | (11) OVX + ELP + R (Low) | OVX treated with 0.35 g/kg/day ELP + 0.25 mg/kg/day raloxifene |
|
|